The AI-based mammography screening paper by Google scientists first published in Nature is bringing public awareness to one of the most promising fields of artificial intelligence, presenting the perfect opportunity for CureMetrix to highlight our AI-driven mammography solutions that are already in the market saving today. Highlighted in the Journal of Digital Imaging in April 2019, CureMetrix is currently being used to support radiologists in clinics in the US, Brazil, and Mexico.
Artificial Intelligence (AI) has arrived in radiology and is quickly moving from the lab to clinical use. A recent survey shows that healthcare executives are not only embracing the use of artificial intelligence, they’re making budgetary plans to bring the technology into their organizations.
We are honored to share the news that CureMetrix was selected by an esteemed panel of industry and clinical experts as the Best New Radiology Vendor for 2019 https://www.einpresswire.com/article/500004616/curemetrix-wins-best-new-radiology-vendor-of-the-year
Artificial intelligence (AI) in healthcare has evolved quickly, and today interest is surging. After its early days in R&D and testing, we’re now seeing the emergence of powerful FDA-cleared products with vast potential to reshape and enhance patient screening, diagnosis and treatment.